Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
Rev. Soc. Bras. Med. Trop
;
54: e20200208, 2021. graf
Article
in English
| SES-SP, ColecionaSUS, LILACS
| ID: biblio-1143878
ABSTRACT
Abstract Post-kala-azar dermal leishmaniasis is a skin disorder occurring in 5-10% of visceral leishmaniasis patients after treatment with miltefosine,the first-line drug for this skin disorder. We reported a case of acute anterior uveitis,a rare adverse effect, experienced by a patient treated with miltefosine for post-kala-azar dermal leishmaniasis. This adverse effect developed after 15 days of miltefosine consumption, and the patient himself discontinued the treatment. The ophthalmic complication was completely resolved with antibiotics and steroid eye drops. After recovery from the ophthalmic complication, the patient was successfully treated with liposomal amphotericin B for the skin lesions.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Uveitis
/
Leishmaniasis, Cutaneous
/
Leishmaniasis, Visceral
/
Antiprotozoal Agents
Limits:
Humans
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Year:
2021
Type:
Article
Institution/Affiliation country:
Indian Council of Medical Research/IN
/
Lovely Professional University/IN
Similar
MEDLINE
...
LILACS
LIS